Cementos Bio-B (CEMENTOS) - Total Assets

Latest as of December 2025: CL$528.13 Billion CLP ≈ $590.64 Million USD

Based on the latest financial reports, Cementos Bio-B (CEMENTOS) holds total assets worth CL$528.13 Billion CLP (≈ $590.64 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore Cementos Bio-B (CEMENTOS) cash flow to debt to assess how comfortably operating cash covers total debt obligations.

Cementos Bio-B - Total Assets Trend (2014–2025)

This chart illustrates how Cementos Bio-B's total assets have evolved over time, based on quarterly financial data. See Cementos Bio-B (CEMENTOS) net assets for net asset value and shareholders' equity analysis.

Cementos Bio-B - Asset Composition Analysis

Current Asset Composition (December 2025)

Cementos Bio-B's total assets of CL$528.13 Billion consist of 32.9% current assets and 67.1% non-current assets.

Asset Category Amount (CLP) % of Total Assets
Cash & Equivalents CL$0.00 8.2%
Accounts Receivable CL$59.38 Billion 11.2%
Inventory CL$53.76 Billion 10.2%
Property, Plant & Equipment CL$0.00 0.0%
Intangible Assets CL$3.51 Billion 0.7%
Goodwill CL$12.48 Billion 2.4%

Asset Composition Trend (2014–2025)

This chart illustrates how Cementos Bio-B's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Cementos Bio-B market cap and net worth.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Cementos Bio-B's current assets represent 32.9% of total assets in 2025, an increase from 22.9% in 2014.
  • Cash Position: Cash and equivalents constituted 8.2% of total assets in 2025, up from 3.7% in 2014.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, unchanged from 2.0% in 2014.
  • Asset Diversification: The largest asset category is accounts receivable at 11.2% of total assets.

Cementos Bio-B Competitors by Total Assets

Key competitors of Cementos Bio-B based on total assets are shown below.

Company Country Total Assets
James Hardie Industries Plc
AU:JHX
Australia AU$13.80 Billion
Huaxin Cement Co Ltd A
SHG:600801
China CN¥81.91 Billion
Loma Negra Compania Industrial Argentina SA
BA:LOMA
Argentina AR$1.85 Trillion
Hanilcmt Co Ltd
KO:300720
Korea ₩2.99 Trillion
Hyundai Cement
KO:006390
Korea ₩906.87 Billion
Vitro S.A.B. de C.V
MX:VITROA
Mexico MX$1.64 Billion
Hoffmann Green Cement Technologies
PA:ALHGR
France €99.91 Million
RIAS A/S
CO:RIAS-B
Denmark Dkr249.76 Million

Cementos Bio-B - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.38 1.29 1.92
Quick Ratio 0.95 0.85 1.39
Cash Ratio 0.00 0.00 0.00
Working Capital CL$47.69 Billion CL$33.76 Billion CL$57.15 Billion

Cementos Bio-B - Advanced Valuation Insights

This section examines the relationship between Cementos Bio-B's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 1.59
Latest Market Cap to Assets Ratio 0.00
Asset Growth Rate (YoY) 1.3%
Total Assets CL$528.13 Billion
Market Capitalization $511.20 Million USD

Valuation Analysis

Below Book Valuation: The market values Cementos Bio-B's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Cementos Bio-B's assets grew by 1.3% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Cementos Bio-B (2014–2025)

The table below shows the annual total assets of Cementos Bio-B from 2014 to 2025.

Year Total Assets Change
2025-12-31 CL$528.13 Billion
≈ $590.64 Million
+1.28%
2024-12-31 CL$521.44 Billion
≈ $583.15 Million
+6.13%
2023-12-31 CL$491.32 Billion
≈ $549.47 Million
+3.27%
2022-12-31 CL$475.75 Billion
≈ $532.05 Million
-2.68%
2021-12-31 CL$488.87 Billion
≈ $546.72 Million
+9.57%
2020-12-31 CL$446.18 Billion
≈ $498.98 Million
+1.78%
2019-12-31 CL$438.37 Billion
≈ $490.25 Million
-2.50%
2018-12-31 CL$449.61 Billion
≈ $502.82 Million
+2.27%
2017-12-31 CL$439.61 Billion
≈ $491.64 Million
-8.09%
2016-12-31 CL$478.33 Billion
≈ $534.93 Million
-0.25%
2015-12-31 CL$479.54 Billion
≈ $536.29 Million
-5.88%
2014-12-31 CL$509.47 Billion
≈ $569.77 Million
--

About Cementos Bio-B

SN:CEMENTOS Chile Building Materials
Market Cap
$511.20 Million
CL$457.10 Billion CLP
Market Cap Rank
#11918 Global
#51 in Chile
Share Price
CL$1730.00
Change (1 day)
+0.00%
52-Week Range
CL$1591.10 - CL$1997.10
All Time High
CL$1997.10
About

Cementos Bio Bio S.A. engages in the production and sale of cement, lime, and concrete products in Chile and internationally. The company operates through Cement and Lime segments. It offers ready-mixed concrete, gypsum, and limestone products. The company is also involved in the manufacture and sale of lime for use in the extraction of silver, gold, lithium, and iodine applications, as well as c… Read more